Supporting translation from research to clinical development
ATMP Norway, the new national framework for advanced therapy medicinal product (ATMP) development, established jointly by Oslo University Hospital and Haukeland University Hospital, will be officially launched on September 14 as part of a mini-symposium, the ATMP Forum.
The event brings together academia, healthcare, and industry to mark the start of a coordinated national effort to strengthen pre-GMP and GMP capacity, quality control, training, and regulatory support for cell and gene therapies in Norway.
See the full program and register on our event page
ATMP Norway will be a national single point of entry to get access to facilities and support to bring new advanced medical therapy products forward to clinical studies.
Interested in project access?
Researchers and industry partners can contact ATMP Norway for a preliminary discussion before submitting a full project proposal.
asdf